SHARP THERAPEUTICS CORP (SHRX.CA) Stock Overview
Canada - TSX-V:SHRX - CA8200092077 - Common Stock
SHRX.CA Key Statistics, Chart & Performance
The current stock price of SHRX.CA is 3.62 CAD. In the past month the price increased by 262%.
SHRX.CA Latest News, Press Relases and Analysis
About SHRX.CA
Company Profile
Sharp Therapeutics Corp. operates as a biology technology company. The company is headquartered in Pittsburgh, Pennsylvania. The company went IPO on 2023-08-04. Its discovery platform combines high throughput screening technologies, with compound libraries computational optimized based on the physics and biology of cellular trafficking defects and allosteric activation of proteins. The platform produces small molecule compounds that restore activity in mutated proteins giving the potential to treat genetic disorders with conventional pill-based medicines. Its technology includes CoreX assay technology, AlloChem compound libraries, and mine data system and machine learning layer. Its advanced programs include a small molecule that prevents the degradation of the neuroprotective protein progranulin, thus increasing progranulin levels preventing neurodegeneration, and a small molecule that restores activity of mutated GCase protein (mutation and loss of activity of GCase is the genetic cause of Gaucher’s disease).
Company Info
SHARP THERAPEUTICS CORP
2403 Sidney St, Suite 264
Pittsburgh PENNSYLVANIA US
Employees: 0
Phone: 14122065303
SHARP THERAPEUTICS CORP / SHRX.CA FAQ
Can you describe the business of SHARP THERAPEUTICS CORP?
Sharp Therapeutics Corp. operates as a biology technology company. The company is headquartered in Pittsburgh, Pennsylvania. The company went IPO on 2023-08-04. Its discovery platform combines high throughput screening technologies, with compound libraries computational optimized based on the physics and biology of cellular trafficking defects and allosteric activation of proteins. The platform produces small molecule compounds that restore activity in mutated proteins giving the potential to treat genetic disorders with conventional pill-based medicines. Its technology includes CoreX assay technology, AlloChem compound libraries, and mine data system and machine learning layer. Its advanced programs include a small molecule that prevents the degradation of the neuroprotective protein progranulin, thus increasing progranulin levels preventing neurodegeneration, and a small molecule that restores activity of mutated GCase protein (mutation and loss of activity of GCase is the genetic cause of Gaucher’s disease).
What is the stock price of SHARP THERAPEUTICS CORP today?
The current stock price of SHRX.CA is 3.62 CAD. The price decreased by -0.28% in the last trading session.
Does SHARP THERAPEUTICS CORP pay dividends?
SHRX.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of SHRX stock?
SHRX.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the Price/Earnings (PE) ratio of SHARP THERAPEUTICS CORP (SHRX.CA)?
SHARP THERAPEUTICS CORP (SHRX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.22).
Should I buy SHRX stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SHRX.CA.
What is SHARP THERAPEUTICS CORP worth?
SHARP THERAPEUTICS CORP (SHRX.CA) has a market capitalization of 108.64M CAD. This makes SHRX.CA a Micro Cap stock.
SHRX.CA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to SHRX.CA.
SHRX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SHRX.CA. SHRX.CA may be in some trouble as it scores bad on both profitability and health.
SHRX.CA Financial Highlights
Over the last trailing twelve months SHRX.CA reported a non-GAAP Earnings per Share(EPS) of -4.22. The EPS decreased by -18018.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -138.59% | ||
| ROE | -238.08% | ||
| Debt/Equity | 0.51 |